12.12.2012Algeta’s partner Bayer submits Radium-223 Dichloride for EU Marketing Authorisation

Submission to trigger €50 million milestone payment to Algeta

Press Release

05.09.2012F2G Ltd Completes $30 Million Financing Round to Fund Pre-clinical and Clinical Development of Novel Anti-fungal Compounds

Antifungal drug discovery and development company announces the completion of a $30 million equity financing round

Press Release

10.07.2012Advent Life Sciences Fund I Receives Additional Investments

Final Fund Size of £101.3 Million ($158 Million)

Press Release

10.06.2012Need a light? It’s okay, I’ll just plug it in

Matthew Goodman from the Sunday Times explores the growth in electronic cigarettes

In The News

30.05.2012CN CREATIVE ADVANCES REGULATORY INITIATIVES FOR ITS NICADEX™ AND INTELLICIG®

MANCHESTER, UK, May 30, 2012 – CN Creative, Ltd. (CNC), a healthcare company providing innovative and sustainable solutions to reduce smoking and smoking-related illnesses, today reported advances in the company’s regulatory and market initiatives for its Nicadex™ electronic inhaler nicotine replacement therapy (NRT) product and Intellicig® electronic cigarettes.

Press Release